These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 12838269)

  • 1. Clinical biomarkers in drug discovery and development.
    Frank R; Hargreaves R
    Nat Rev Drug Discov; 2003 Jul; 2(7):566-80. PubMed ID: 12838269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarker assay translation from discovery to clinical studies in cancer drug development: quantification of emerging protein biomarkers.
    Lee JW; Figeys D; Vasilescu J
    Adv Cancer Res; 2007; 96():269-98. PubMed ID: 17161683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease).
    Roses AD; Saunders AM; Huang Y; Strum J; Weisgraber KH; Mahley RW
    Pharmacogenomics J; 2007 Feb; 7(1):10-28. PubMed ID: 16770341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New science-based endpoints to accelerate oncology drug development.
    Kelloff GJ; Sigman CC
    Eur J Cancer; 2005 Mar; 41(4):491-501. PubMed ID: 15737552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of gene array technology and proteomics in the search of new targets of diseases for therapeutics.
    Ferrer-Alcón M; Arteta D; Guerrero MJ; Fernandez-Orth D; Simón L; Martinez A
    Toxicol Lett; 2009 Apr; 186(1):45-51. PubMed ID: 19022361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarker discovery: validation and decision-making in product development.
    Niedbala RS; Mauck C; Harrison P; Doncel GF
    Sex Transm Dis; 2009 Mar; 36(3 Suppl):S76-80. PubMed ID: 19218888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promises of biomarkers in drug development--a reality check.
    Marrer E; Dieterle F
    Chem Biol Drug Des; 2007 Jun; 69(6):381-94. PubMed ID: 17581232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular profiling approaches for identifying novel biomarkers.
    Bailey WJ; Ulrich R
    Expert Opin Drug Saf; 2004 Mar; 3(2):137-51. PubMed ID: 15006720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applying pharmacogenomics to enhance the use of biomarkers for drug effect and drug safety.
    Beitelshees AL; McLeod HL
    Trends Pharmacol Sci; 2006 Sep; 27(9):498-502. PubMed ID: 16876261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel biomarkers of acute kidney toxicity.
    Goodsaid FM; Blank M; Dieterle F; Harlow P; Hausner E; Sistare F; Thompson A; Vonderscher J
    Clin Pharmacol Ther; 2009 Nov; 86(5):490-6. PubMed ID: 19710639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of molecular imaging in drug discovery and development.
    Hargreaves RJ
    Clin Pharmacol Ther; 2008 Feb; 83(2):349-53. PubMed ID: 18167503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular biomarkers in drug development.
    Lewin DA; Weiner MP
    Drug Discov Today; 2004 Nov; 9(22):976-83. PubMed ID: 15539141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges of drug discovery for personalized medicine.
    Jain KK
    Curr Opin Mol Ther; 2006 Dec; 8(6):487-92. PubMed ID: 17243483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolomics and biochemical profiling in drug discovery and development.
    Watkins SM; German JB
    Curr Opin Mol Ther; 2002 Jun; 4(3):224-8. PubMed ID: 12139307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using imaging biomarkers to accelerate drug development and clinical trials.
    Pien HH; Fischman AJ; Thrall JH; Sorensen AG
    Drug Discov Today; 2005 Feb; 10(4):259-66. PubMed ID: 15708744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic and genetic biomarkers of toxicity.
    Mendrick DL
    Toxicology; 2008 Mar; 245(3):175-81. PubMed ID: 18206287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Biomarkers Consortium: on the critical path of drug discovery.
    Altar CA
    Clin Pharmacol Ther; 2008 Feb; 83(2):361-4. PubMed ID: 18183037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamic biomarkers for molecular cancer therapeutics.
    Sarker D; Workman P
    Adv Cancer Res; 2007; 96():213-68. PubMed ID: 17161682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional genomics and proteomics in the clinical neurosciences: data mining and bioinformatics.
    Phan JH; Quo CF; Wang MD
    Prog Brain Res; 2006; 158():83-108. PubMed ID: 17027692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.